{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:04:43Z","timestamp":1789362283300,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Alopecia areata (AA) and systemic lupus erythematosus (SLE) are distinct autoimmune entities that can present with overlapping clinical features of non-scarring alopecia. We report a case of a 35-year-old woman with a 9-month history of severe, progressive patchy alopecia that was refractory to baricitinib. Subsequent serological workup led to a diagnosis of SLE. The patient demonstrated significant clinical improvement following treatment with the selective Janus kinase (JAK) 1 inhibitor ivarmacitinib. Trichoscopy performed 8 months post-treatment revealed features supportive of both AA (exclamation mark hairs, black dots, broken hairs, yellow dots) and lupus-associated alopecia (follicular telangiectasia), suggesting coexisting AA and SLE. This case highlights the diagnostic challenge posed by overlapping hair loss disorders and provides preliminary evidence for the potential therapeutic utility of ivarmacitinib in this clinical context. Furthermore, we sought further evidence from the literature to support the use of JAK inhibitors in lupus-associated alopecia.<\/jats:p>","DOI":"10.3389\/fmed.2026.1886998","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:34:57Z","timestamp":1789360497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenjie","family":"Li","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxin","family":"Huang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Mei","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengdong","family":"Shen","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Chu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Zhuhai Branch of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/0961203310373938","article-title":"Involvement of scalp and nails in lupus erythematosus","volume":"19","author":"Tr\u00fceb","year":"2010","journal-title":"Lupus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000521549","article-title":"Areata-like lupus as a clinical manifestation of cutaneous lupus erythematosus","volume":"8","author":"Morais","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s40257-018-0363-8","article-title":"Hair and scalp changes in cutaneous and systemic lupus erythematosus","volume":"19","author":"Udompanich","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40257-023-00774-8","article-title":"Cutaneous lupus erythematosus: an update on pathogenesis and future therapeutic directions","volume":"24","author":"Niebel","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103648","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Arnaud","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.063","article-title":"A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata","volume":"89","author":"Zhou","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e945068","DOI":"10.12659\/ajcr.945068","article-title":"Alopecia areata following the use of belimumab in a patient with systemic lupus erythematosus and arthritis who responded well to baricitinib: a case report","volume":"25","author":"Almoallim","year":"2024","journal-title":"Am J Case Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/03009742.2022.2087901","article-title":"Efficacy of low-dose of baricitinib in the treatment of patchy alopecia and sicca syndrome in an SLE patient","volume":"51","author":"Chen","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/annrheumdis-2019-216571","article-title":"Efficacy of JAK 1\/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus","volume":"79","author":"Maeshima","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"654376","DOI":"10.3389\/fimmu.2021.654376","article-title":"Case report: reversal of long-standing refractory diffuse non-scarring alopecia due to systemic lupus erythematosus following treatment with tofacitinib","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jdcr.2024.04.032","article-title":"Discoid lupus erythematosus successfully treated with deucravacitinib","volume":"49","author":"Ezeh","year":"2024","journal-title":"JAAD Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/ced.15044","article-title":"Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia","volume":"47","author":"Kreuter","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050313X241304891","article-title":"Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: a case report","volume":"13","author":"Aw","year":"2025","journal-title":"SAGE Open Med Case Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s10067-023-06632-6","article-title":"Refractory alopecia in lupus treated with tofacitinib - a case-based review","volume":"42","author":"Sarkar","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/archderm.1992.01680130082010","article-title":"Incidence of alopecia areata in lupus erythematosus","volume":"128","author":"Werth","year":"1992","journal-title":"Arch Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/ijd.17895","article-title":"Immune-mediated disorders in patients with alopecia areata: systematic review and meta-analysis","volume":"64","author":"Krajewski","year":"2025","journal-title":"Int J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/bjd\/ljad381","article-title":"Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data","volume":"190","author":"Augustin","year":"2024","journal-title":"Br J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00403-022-02444-x","article-title":"Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women","volume":"315","author":"Moseley","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000520825","article-title":"Epidemiological, clinical, trichoscopic, and histopathological features of lupus erythematous mimicking alopecia areata: a multicenter retrospective study","volume":"8","author":"Melo","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1177\/0961203313508833","article-title":"Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata","volume":"22","author":"Ye","year":"2013","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/dad.0000000000003115","article-title":"Lupus panniculitis of the scalp presenting as a patchy nonscarring alopecia: report of an uncommon case","volume":"47","author":"Behera","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.annder.2023.04.002","article-title":"Non-scarring alopecia of lupus erythematosus: a comprehensive review","volume":"150","author":"Perales","year":"2023","journal-title":"Ann Dermatol Venereol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/ijd.IJD_477_17","article-title":"A study of the histopathological features of Alopecias on transverse sections of scalp biopsies","volume":"64","author":"Goyal","year":"2019","journal-title":"Indian J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-025-00664-9","article-title":"Alopecia areata","volume":"11","author":"Ungar","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/annrheumdis-2020-219012","article-title":"JAK Selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib","volume":"80","author":"Traves","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaad.2024.06.097","article-title":"Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: results from the phase 3 randomized, controlled trial (THRIVE-AA1)","volume":"91","author":"King","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2025.09.044","article-title":"Ivarmacitinib for the treatment of adults with severe alopecia areata: results from a phase 3 trial","volume":"94","author":"Zhou","year":"2026","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1886998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:35:03Z","timestamp":1789360503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1886998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":30,"alternative-id":["10.3389\/fmed.2026.1886998"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1886998","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1886998"}}